Read + Share
Bourgeois W, Cutler JA, Aubrey BJ, Wenge DV, et al. Mezigdomide is effective alone and in combination with menin inhibition in
preclinical models of KMT2A-r and NPM1c AML. Blood 2024;143:1513-1527.
PMID: 38096371
|
 |
|
Bourgeois W, Cutler JA, Aubrey BJ, Wenge DV, et al. Mezigdomide is effective alone and in combination with menin inhibition in
preclinical models of KMT2A-r and NPM1c AML. Blood 2024;143:1513-1527.
PMID: 38096371
|
|
|
|